1. United States
  2. Nev.
  3. Letter

HHS DEREGULATING RESEARCH AND DEVELOPMENT on biosimilar generic drugs?!

To: Sen. Cortez Masto, Rep. Lee, Sen. Rosen

From: A constituent in Las Vegas, NV

November 1

HHS held a news briefing today. HHS Secretary RFK Jr unveiled the nationwide plan to cut prescription prices on 'biosimilar' pharmaceuticals. RFK Jr and Mehmet Oz were among the presenters. It is my understanding that HHS is going to be DEREGULATING RESEARCH AND DEVELOPMENT to roll out cheaper 'biologic' biosimilar generic drugs. "Trump RX" was mentioned by Mehmet Oz, but he didn't go into details. Is Trump going into the pharmaceutical business? I'm very concerned about their announcement, especially if they are rolling back safety measures on drug research and development to rush pharmaceuticals into the market. Please look into this. How do they expect people to benefit from any cheaper drug if they can't afford health insurance to go see a doctor? The doctor provides the prescription to have access to the 'cheaper' drugs. Seems like a cart before the horse scenario. Thank you.

Share on BlueskyShare on TwitterShare on FacebookShare on LinkedInShare on WhatsAppShare on TumblrEmail with GmailEmail

Write to Catherine Cortez Masto or any of your elected officials

Send your own letter

Resistbot is a chatbot that delivers your texts to your elected officials by email, fax, or postal mail. Tap above to give it a try or learn more here!